(ASPN) Aspen Aerogels - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US04523Y1055

Aerogel Materials, Insulation Materials, Thermal Barriers, Energy Storage

ASPN EPS (Earnings per Share)

EPS (Earnings per Share) of ASPN over the last years for every Quarter: "2020-03": -0.12578241903923, "2020-06": -0.21484131981495, "2020-09": -0.25265449974185, "2020-12": -0.2287562372944, "2021-03": -0.22334590026265, "2021-06": -0.23399178976176, "2021-09": -0.24050376036946, "2021-12": -0.50085144439272, "2022-03": -0.61760777170613, "2022-06": -0.6830833901386, "2022-09": -0.78113103504099, "2022-12": -0.19414357925802, "2023-03": -0.21628710273023, "2023-06": -0.22271705273555, "2023-09": -0.18859513717977, "2023-12": -0.0074123585010754, "2024-03": -0.024220297797471, "2024-06": 0.21293621029761, "2024-09": -0.17046721128755, "2024-12": 0.13689321558091, "2025-03": -3.6708137352862, "2025-06": -0.1101983350998,

ASPN Revenue

Revenue of ASPN over the last years for every Quarter: 2020-03: 28.419, 2020-06: 24.641, 2020-09: 24.195, 2020-12: 23.018, 2021-03: 28.097, 2021-06: 31.67, 2021-09: 30.38, 2021-12: 31.475, 2022-03: 38.407, 2022-06: 45.64, 2022-09: 36.706, 2022-12: 59.611, 2023-03: 45.586, 2023-06: 48.158, 2023-09: 60.755, 2023-12: 84.219, 2024-03: 94.501, 2024-06: 117.77, 2024-09: 117.34, 2024-12: 123.088, 2025-03: 78.723, 2025-06: 78.024,

Description: ASPN Aspen Aerogels

Aspen Aerogels Inc (NYSE:ASPN) is a technology company specializing in aerogel materials for energy industrial, sustainable insulation, and electric vehicle (EV) markets globally. The companys products cater to various industries, including EV manufacturers, automotive suppliers, and energy storage companies, with applications in battery packs, refineries, petrochemical facilities, and offshore oil production.

From a market perspective, Aspen Aerogels operates in a niche segment, leveraging its aerogel technology to provide high-performance insulation solutions. The companys product portfolio includes PyroThin, Pyrogel XTE, Pyrogel HPS, and Cryogel Z, among others, which are designed to meet specific thermal management requirements. With a global presence, Aspen Aerogels serves customers across the United States, Canada, Asia, Europe, and Latin America.

To evaluate the companys performance, we can look at key performance indicators (KPIs) such as revenue growth, gross margin, and operating expenses. Given the companys negative return on equity (RoE) of -58.53%, it is likely that Aspen Aerogels is investing heavily in research and development, sales, and marketing to drive growth. The forward P/E ratio of 47.62 suggests that investors expect significant earnings growth in the future. Additionally, the market capitalization of $470.86M USD indicates a relatively small-cap stock with potential for volatility.

From a technical analysis perspective, the stocks price is currently at $6.14, with a 20-day simple moving average (SMA) of $6.04 and a 50-day SMA of $5.84, indicating a short-term uptrend. However, the 200-day SMA at $11.88 suggests a longer-term downtrend. The average true range (ATR) of 0.36, representing a 5.86% daily price range, indicates moderate volatility. With a 52-week high of $31.72 and a low of $4.31, the stock has experienced significant price fluctuations, warranting caution and further analysis.

ASPN Stock Overview

Market Cap in USD 563m
Sub-Industry Oil & Gas Equipment & Services
IPO / Inception 2014-06-13

ASPN Stock Ratings

Growth Rating -49.1%
Fundamental 33.3%
Dividend Rating -
Return 12m vs S&P 500 -79.7%
Analyst Rating 4.22 of 5

ASPN Dividends

Currently no dividends paid

ASPN Growth Ratios

Growth Correlation 3m 71%
Growth Correlation 12m -82.6%
Growth Correlation 5y -43.6%
CAGR 5y -4.27%
CAGR/Max DD 5y -0.05
Sharpe Ratio 12m -2.05
Alpha -102.87
Beta 1.772
Volatility 81.46%
Current Volume 1049.3k
Average Volume 20d 1684.6k
Stop Loss 6.4 (-6.4%)
Signal -1.88

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (-311.9m TTM) > 0 and > 6% of Revenue (6% = 23.8m TTM)
FCFTA -0.08 (>2.0%) and ΔFCFTA 21.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 58.52% (prev 57.41%; Δ 1.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.11 (>3.0%) and CFO 58.2m > Net Income -311.9m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 3.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (82.2m) change vs 12m ago 4.05% (target <= -2.0% for YES)
Gross Margin 36.33% (prev 36.43%; Δ -0.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 62.36% (prev 47.72%; Δ 14.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -18.23 (EBITDA TTM -181.6m / Interest Expense TTM 11.2m) >= 6 (WARN >= 3)

Altman Z'' -9.98

(A) 0.44 = (Total Current Assets 310.5m - Total Current Liabilities 78.0m) / Total Assets 525.1m
(B) -1.85 = Retained Earnings (Balance) -970.5m / Total Assets 525.1m
warn (B) unusual magnitude: -1.85 — check mapping/units
(C) -0.32 = EBIT TTM -203.9m / Avg Total Assets 636.9m
(D) -4.49 = Book Value of Equity -970.5m / Total Liabilities 216.4m
Total Rating: -9.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 33.27

1. Piotroski 2.50pt = -2.50
2. FCF Yield -7.59% = -3.79
3. FCF Margin -10.25% = -3.84
4. Debt/Equity 0.46 = 2.40
5. Debt/Ebitda -0.78 = -2.50
6. ROIC - WACC -45.33% = -12.50
7. RoE -71.47% = -2.50
8. Rev. Trend 76.47% = 3.82
9. Rev. CAGR 31.55% = 2.50
10. EPS Trend -12.40% = -0.31
11. EPS CAGR 50.94% = 2.50

What is the price of ASPN shares?

As of August 31, 2025, the stock is trading at USD 6.84 with a total of 1,049,305 shares traded.
Over the past week, the price has changed by -2.43%, over one month by -12.31%, over three months by +14.77% and over the past year by -76.20%.

Is Aspen Aerogels a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Aspen Aerogels (NYSE:ASPN) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 33.27 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ASPN is around 5.65 USD . This means that ASPN is currently overvalued and has a potential downside of -17.4%.

Is ASPN a buy, sell or hold?

Aspen Aerogels has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy ASPN.
  • Strong Buy: 4
  • Buy: 3
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ASPN price?

Issuer Target Up/Down from current
Wallstreet Target Price 9.6 40.1%
Analysts Target Price 13.3 94.3%
ValueRay Target Price 6.4 -6.3%

Last update: 2025-08-21 02:49

ASPN Fundamental Data Overview

Market Cap USD = 563.3m (563.3m USD * 1.0 USD.USD)
CCE Cash And Equivalents = 168.0m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 47.619
P/S = 1.4184
P/B = 1.8245
Beta = 2.732
Revenue TTM = 397.2m USD
EBIT TTM = -203.9m USD
EBITDA TTM = -181.6m USD
Long Term Debt = 106.3m USD (from longTermDebt, last quarter)
Short Term Debt = 34.9m USD (from shortTermDebt, last quarter)
Debt = 141.1m USD (Calculated: Short Term 34.9m + Long Term 106.3m)
Net Debt = 5.14m USD (from netDebt column, last quarter)
Enterprise Value = 536.4m USD (563.3m + Debt 141.1m - CCE 168.0m)
Interest Coverage Ratio = -18.23 (Ebit TTM -203.9m / Interest Expense TTM 11.2m)
FCF Yield = -7.59% (FCF TTM -40.7m / Enterprise Value 536.4m)
FCF Margin = -10.25% (FCF TTM -40.7m / Revenue TTM 397.2m)
Net Margin = -78.54% (Net Income TTM -311.9m / Revenue TTM 397.2m)
Gross Margin = 36.33% ((Revenue TTM 397.2m - Cost of Revenue TTM 252.9m) / Revenue TTM)
Tobins Q-Ratio = -0.55 (set to none) (Enterprise Value 536.4m / Book Value Of Equity -970.5m)
Interest Expense / Debt = 2.18% (Interest Expense 3.08m / Debt 141.1m)
Taxrate = 11.36% (from yearly Income Tax Expense: 1.71m / 15.1m)
NOPAT = -203.9m (EBIT -203.9m, no tax applied on loss)
Current Ratio = 3.98 (Total Current Assets 310.5m / Total Current Liabilities 78.0m)
Debt / Equity = 0.46 (Debt 141.1m / last Quarter total Stockholder Equity 308.8m)
Debt / EBITDA = -0.78 (Net Debt 5.14m / EBITDA -181.6m)
Debt / FCF = -3.47 (Debt 141.1m / FCF TTM -40.7m)
Total Stockholder Equity = 436.5m (last 4 quarters mean)
RoA = -59.40% (Net Income -311.9m, Total Assets 525.1m )
RoE = -71.47% (Net Income TTM -311.9m / Total Stockholder Equity 436.5m)
RoCE = -37.56% (Ebit -203.9m / (Equity 436.5m + L.T.Debt 106.3m))
RoIC = -34.92% (NOPAT -203.9m / Invested Capital 583.9m)
WACC = 10.42% (E(563.3m)/V(704.5m) * Re(12.54%)) + (D(141.1m)/V(704.5m) * Rd(2.18%) * (1-Tc(0.11)))
Shares Correlation 5-Years: 90.0 | Cagr: 25.96%
Discount Rate = 12.54% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -40.7m)
Revenue Correlation: 76.47 | Revenue CAGR: 31.55%
Rev Growth-of-Growth: -48.06
EPS Correlation: -12.40 | EPS CAGR: 50.94%
EPS Growth-of-Growth: -201.8

Additional Sources for ASPN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle